Cargando…
Copper chelation as a potential treatment for left-ventricular hypertrophy in type 2 diabetes
Autores principales: | Bakker, S. J. L., Navis, G., Gans, R. O. B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744789/ https://www.ncbi.nlm.nih.gov/pubmed/19690830 http://dx.doi.org/10.1007/s00125-009-1495-4 |
Ejemplares similares
-
Left ventricular hypertrophy, inflammation, and insulin resistance
por: Öncel, Can Ramazan
Publicado: (2016) -
Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment
por: Lu, Jun, et al.
Publicado: (2013) -
Left ventricular hypertrophy in hypertension: Is the electrocardiogram enough for risk stratification?
por: Cuspidi, Cesare, et al.
Publicado: (2022) -
Left ventricular hypertrophy in hypertension: Need of ethnic‐specific criteria
por: Cuspidi, Cesare, et al.
Publicado: (2022) -
Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community
por: Somaratne, Jithendra B, et al.
Publicado: (2011)